VIKING GLOBAL INVESTORS LP 13D/13G Filings for Athira Pharma, Inc. (ATHA)

VIKING GLOBAL INVESTORS LP 13D and 13G filings for Athira Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
5:02 pm
Sale		 2021-12-31 13G Athira Pharma, Inc.
ATHA		 VIKING GLOBAL INVESTORS LP 0
0.000%		 -2,120,653decrease
(Position Closed)		 Filing
2021-02-12
7:55 pm
Unchanged		 2020-12-31 13G Athira Pharma, Inc.
ATHA		 VIKING GLOBAL INVESTORS LP 2,120,653
6.000%		 0
(Unchanged)		 Filing
2020-09-28
5:04 pm
Purchase		 2020-09-18 13G Athira Pharma, Inc.
ATHA		 VIKING GLOBAL INVESTORS LP 2,120,653
6.900%		 2,120,653increase
(New Position)		 Filing